Abstract
ANTIBODIES to DNA and nucleoproteins are found in sera of individuals with systemic autoimmune disease. In the population (and in the autoimmune mouse strain MRL/lpr) there is a great variety of such antinuclear antibodies, but individuals with systemic lupus erythematosus or single MRL mice express a subset only of the antinuclear specificities found in the population. These observations have been interpreted to mean that these antibodies arise by immunization1. The oligoclonal nature of the autoantibody response and the evidence of selection acting on somatically mutated autoantibodies favour this interpretation2,3. Specific activation of autoantibodies in disease implies either that autoantibodies are regulated in non-diseased individuals or that autoantigen availability is variable. The former has been demonstrated in anti-DNA transgenic mice. In normal mice, transgene-encoded antibodies against double-stranded (ds) DNA are not expressed in serum or on B cells4–6. Here we describe modified anti-dsDNA transgenic mice which allow us to study the site and developmental stage at which such B-cell regulation occurs. This model shows that in normal mice B cells expressing anti-DNA specificity are deleted in the bone marrow at a pre-B to immature B transitional stage.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hardin, J. A. Arthritis Rheum. 29, 457–460 (1986).
Shlomchik, M. J., Marshak-Rothstein, A., Wolfowicz, C. B., Rothstein, T. L. & Weigert, M. G. Nature 328, 805–811 (1987).
Shlomchik, M. J., Aucoin, A. H., Pisetsky, D. S. & Weigert, M. G. Proc. natn. Acad. Sci. U.S.A. 84, 9150–9154 (1987).
Erikson, J., Radic, M. Z., Camper, S. A., Hardy, R. R. & Weigert, M. G. Nature 349, 331–334 (1991).
Gay, D., Saunders, T., Camper, S. & Weigert, M. J. exp. Med. 177, 999–1008 (1993).
Chen, C. et al. J. Immun. 152, 1970–1982 (1994).
Radic, M. Z. & Weigert, M. A. Rev. Immun. 12, 487–520 (1994).
Radic, M. Z., Mascelli, M. A., Erikson, J., Shan, H. & Weigert, M. J. Immun. 146, 176–182 (1991).
Tiegs, S. L., Russell, D. M. & Nemazee, D. J. exp. Med. 177, 1009–1020 (1993).
Radic, M. Z., Erikson, J., Litwin, S. & Weigert, M. J. exp. Med. 177, 1165–1173 (1993).
Radic, M. Z. et al. J. Immun. 150, 4966–4977 (1993).
Chen, J. et al. Int. Immun. 5, 647–656 (1993).
Hardy, R. R., Carmack, C. E., Shinton, S. A., Kemp, J. D. & Hayakawa, K. J. exp. Med. 173, 1213–1225 (1991).
Allman, D. M., Ferguson, S. E., Lentz, V. M. & Cancro, M. P. J. Immun. 151, 4431–4444 (1993).
Ehlich, A. et al. Cell 72, 695–704 (1993).
Goodnow, C. C. et al. Nature 334, 676–682 (1988).
Nemazee, D. A. & Burki, K. Nature 337, 562–566 (1989).
Hartley, S. B. et al. Nature 353, 765–769 (1991).
Nemazee, D. et al. Immun. Rev. 122, 117–132 (1991).
Hartley, S. B. et al. Cell 72, 325–335 (1993).
Casciola-Rosen, L. A., Anhalt, G. & Rosen, A. J. exp. Med. 179, 1317–1330 (1994).
Marion, T. N., Tillman, D. M. & Jou, N-T. J. Immun. 145, 2322–2332 (1990).
Shlomchik, M. J. et al. J. exp. Med. 171, 265–297 (1990).
Eilat, D., Webster, D. M. & Rees, A. R. J. Immun. 141, 1745–1753 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chen, C., Nagy, Z., Radic, M. et al. The site and stage of anti-DNA B-cell deletion. Nature 373, 252–255 (1995). https://doi.org/10.1038/373252a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/373252a0
This article is cited by
-
Anti-cytokine autoantibodies: mechanistic insights and disease associations
Nature Reviews Immunology (2024)
-
Identification of autoreactive B cells with labeled nucleosomes
Scientific Reports (2017)
-
Mechanisms of central tolerance for B cells
Nature Reviews Immunology (2017)
-
Murine lupus susceptibility locus Sle2 activates DNA-reactive B cells through two sub-loci with distinct phenotypes
Genes & Immunity (2011)
-
Understanding B-cell tolerance through the use of immunoglobulin transgenic models
Immunologic Research (2008)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.